Webinar: Randomization and the Limits of Precision Oncology
Publié le
WATCH RECORDED WEBINAR Drug development in oncology is undergoing several changes brought about by precision medicine, which makes it appealing…
Publié le
WATCH RECORDED WEBINAR Drug development in oncology is undergoing several changes brought about by precision medicine, which makes it appealing…
Publié le
Nowadays, drug development in oncology is largely centered on the basic premise of precision medicine, according to which targeted agents…
Publié le
Adaptations to tumor response and progression criteria for immune therapies. Abstract Immuno-oncology is a buoyant field of research, with recently…
Publié le
Listen to IDDI Podcast on IDDI Services Vicky Martin, Sr Business Director US , IDDI Learn more on IDDI…
Publié le
Free Live Webinar: Assessing Treatment Benefit in Immuno-Oncology In this webinar we reviewed key issues related to endpoints in immuno-oncology,…
Publié le
A New Statistical Method: Generalized Pairwise Comparisons to Assess Treatment Benefit/Risk IN THIS WEBINAR OUR SPEAKERS DESCRIBED A NEW STATISTICAL METHOD,…
Publié le
IDDI in the Media BIOWIN Newsletter Deux projets de R&D dans les starting-blocks (July 2017): “TREATBEST, est un consortium composé…
Publié le
IDDI organized a webinar on Personalized Cancer Medicine Needs Randomized Trials. Clinical cancer research is undergoing profound changes, mostly because…
Publié le
We have experience in the challenging statistical issues that characterize the identification and validation of biomarkers for personalized medicine that have diagnostic utility,…